Answers are grounded in this paper and cite their sources.
Vascular disease, inflammation and impaired brain insulin signaling might occur in T2D and contribute to dementia risk. Evidence from epidemiological studies has not consistently reported associations that could integrate a unified mechanism of disease in humans. Evaluation of the effect of antidiabetic medications and non-pharmacological interventions in dementia prevention in type 2 diabetes is promising but has thus far offered inconsistent results.
No takes yet. Share an insight, caveat, or question.
Bello‐Chavolla et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: